IRIS PubliCatt

Bentivoglio, Anna Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.809
NA - Nord America 7.504
AS - Asia 2.962
AF - Africa 80
SA - Sud America 39
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 15
Totale 18.428
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.443
DE - Germania 2.634
CN - Cina 1.279
SE - Svezia 1.273
IT - Italia 884
UA - Ucraina 847
SG - Singapore 757
FR - Francia 578
IE - Irlanda 458
GB - Regno Unito 342
ID - Indonesia 273
FI - Finlandia 232
IN - India 232
RU - Federazione Russa 226
HK - Hong Kong 141
TR - Turchia 136
BE - Belgio 70
NL - Olanda 68
CI - Costa d'Avorio 66
PL - Polonia 51
JP - Giappone 41
CA - Canada 40
IR - Iran 37
ES - Italia 23
BR - Brasile 22
CZ - Repubblica Ceca 21
AT - Austria 18
AU - Australia 18
MX - Messico 18
IL - Israele 16
CH - Svizzera 14
RO - Romania 14
KR - Corea 13
EU - Europa 12
LT - Lituania 10
VN - Vietnam 9
CL - Cile 7
DK - Danimarca 6
HU - Ungheria 6
BG - Bulgaria 5
CO - Colombia 5
EG - Egitto 5
LU - Lussemburgo 5
PT - Portogallo 5
GR - Grecia 4
KE - Kenya 4
MY - Malesia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
EE - Estonia 3
MD - Moldavia 3
PA - Panama 3
ZA - Sudafrica 3
AM - Armenia 2
BD - Bangladesh 2
BO - Bolivia 2
IQ - Iraq 2
LV - Lettonia 2
NO - Norvegia 2
RS - Serbia 2
AZ - Azerbaigian 1
BY - Bielorussia 1
DZ - Algeria 1
EC - Ecuador 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 18.428
Salva come PNG Salva come JPEG
Città #
Chandler 1.550
Ashburn 703
Singapore 571
Dublin 455
Jacksonville 451
San Mateo 368
Nanjing 293
Ann Arbor 274
Jakarta 271
Wilmington 243
Dearborn 183
Boston 171
New York 157
Woodbridge 151
Milan 141
Lawrence 140
Nürnberg 137
Moscow 127
Houston 126
Rome 125
Cattolica 122
Izmir 117
Marseille 116
Beijing 105
Redwood City 102
Lancaster 99
Seattle 98
Princeton 95
Boardman 93
Redmond 89
Nanchang 88
Fairfield 82
Munich 78
Shenyang 74
Chicago 68
Brussels 67
Abidjan 66
Norwalk 64
Hebei 58
Jiaxing 56
Mountain View 54
Hangzhou 51
University Park 51
Pune 49
Helsinki 47
Bremen 45
Tianjin 45
Changsha 43
Kunming 42
Warsaw 40
Leawood 38
Los Angeles 35
Shanghai 33
Trieste 32
Zhengzhou 32
London 30
Fremont 29
Guangzhou 27
Simi Valley 24
Washington 24
Frankfurt am Main 23
Augusta 22
Cambridge 21
Falkenstein 21
Falls Church 20
Hong Kong 19
Toronto 19
Andover 18
Jinan 18
Brno 16
Lappeenranta 16
Kish 15
Vienna 15
Amsterdam 13
Busto Arsizio 13
Detroit 13
Paris 13
San Diego 13
Edinburgh 12
Ningbo 12
Columbus 11
Fuzhou 11
Lanzhou 10
São Paulo 10
Costa Mesa 9
Hefei 9
Phoenix 9
Poitiers 9
Sacramento 9
Taizhou 9
Caserta 8
Council Bluffs 8
Madrid 8
Millbury 8
Ottawa 8
Berlin 7
Changchun 7
Groningen 7
Padova 7
Plainsboro 7
Totale 9.648
Salva come PNG Salva come JPEG
Nome #
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 321
The role of small intestinal bacterial overgrowth in Parkinson's disease 183
Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease 157
Difference in striatal dopamine transporter availability and psychiatric symptoms in Parkinson's disease subtypes: 123I-FP-CIT SPECT results 156
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 146
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 144
Mutation screening of the DYT6/THAP1 gene in Italy 138
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 137
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. 137
PUNDING IN PARKINSON'S DISEASE: THE IMPACT OF PATIANT'S AWARENESS ON DIAGNOSIS 133
The left parietal lobe plays a role in the pathogenesis of blepharospasm? 133
Cognitive outcome five years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 132
Rehabilitation of hypomimia in Parkinson's disease: a feasibility study of two different approaches 132
Emotional Awareness, Relationship Quality, and Satisfaction in Patients With Parkinson's Disease and Their Spousal Caregivers 131
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 129
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease 129
Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia 127
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 126
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 124
Atrofia multisistemica: correlazioni tra caratteristiche cliniche, prove di reflettività cardiovascolare e reperti di risonanza magnetica 123
Dopaminergic agents and nutritional status in Parkinson's disease 123
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 122
Patient's Loss of Empathy Is Associated With Caregiver Burden 122
Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease 118
Assessment of neurological manifestations in hospitalized patients with COVID-19 117
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 116
Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment 115
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 115
Botulinum toxin in the treatment of outlet obstruction constipation due to puborectalis syndrome 111
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 111
Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa responsive parkinsonism 109
Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study 108
Clinical and genetic characteristics of late-onset Huntington's disease 108
Epidemiological, Clinical, and Molecular Study of a Cohort of Italian Parkinson Disease Patients: Association with Glutathione-S-Transferase and DNA Repair Gene Polymorphisms 107
Movement disorders in multiple sclerosis: Causal or coincidental association? 106
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 105
Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview 105
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 104
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 104
Extradural motor cortex stimulation improves gait, speech, and language in a patient with pure akinesia 103
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia. Results of a randomised, placebo-controlled study. 102
Aristotle's illusion reveals interdigit functional somatosensory alterations in focal hand dystonia 102
Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian families 102
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 102
Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy 101
Dystonia gravidarum: a new case with a long follow-up 100
Analysis of blink rate in patients with blepharospasm 100
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 99
Prevalence of spinocellulart ataxia type 2 mutation among ittalian Parkinsonian patients 98
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 98
Tremor in primary adult-onset dystonia: prevalence and associated clinical features 97
Use of ACE-inhibitors and falls in patients with Parkinson's disease 97
Wake and Sleep EEG in Patients With Huntington Disease: An eLORETA Study and Review of the Literature 97
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication 96
Early DEtection of wEaring off in Parkinson disease: the DEEP study 96
New olfactometric findings in Parkinson's disease 96
Blepharospasm with non-satisfactory response to treatment: Our experience with IncobotulinumtoxinA 95
Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth 95
Reliability of Clinical Diagnosis of Dystonia 94
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability 93
Impulsive compulsive behaviours in Parkinson's disease: patients' versus caregivers' perceptions 93
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 91
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report 91
Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease 91
Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis 90
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 90
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 90
Transcranial magnetic stimulation predicts functional recovery after botulinum toxin treatment in stroke patients 90
Rapid Eye Movement Sleep Behavior Disorder: A Window on the Emotional World of Parkinson Disease, A Window on Dreaming 90
Reduced facial expressiveness in Parkinson's disease: A pure motor disorder? 90
Working on asymmetry in Parkinson's disease: randomized, controlled pilot study 90
GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case 89
Tourettism in multiple sclerosis: a case report 89
MANAGEMENT OF PUNDING IN PARKINSON'S DISEASE: AN OPEN-LABEL PROSPECTIVE STUDY 89
DJ-1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7 89
Measuring gait quality in Parkinson’s disease through real-time gait phase recognition 89
A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. 88
Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. 87
Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs Dysport" controlled trial. 87
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 87
Clinical differences between botulinum neurotoxin type A and B 87
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 85
Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson’s disease 85
Phenotypic characterisation of DYT13 primary torsion distonia. 84
Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up 84
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 83
Management of status dystonicus: our experience and review of the literature 83
Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial 83
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 83
Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey 83
Smooth muscle spasms and sphincters. 82
Punding and computer addiction in Parkinson's disease 82
Safety and efficacy of rotigotine in individuals with Parkinson's disease aged 75 and older 82
Gastroenterologia. 82
Neuropsychological features of patients with Parkinson’s disease and impulse control disorders 82
Abnormal gating of somatosensory inputs in essential tremor. 81
Levodopa effect on electromyographic activation patterns of tibialis anterior muscle during walking in Parkinson's disease 81
The long-term effect of tetrabenazine in the management of Huntington disease 81
Predictive value of the Ewing score to differentiate Parkinson disease from multisystem atrophy. Results of a retrospective 15 year follow-up evaluation of 105 patients 81
Subclinical sensory abnormalities in unaffected PINK1 heterozygotes 81
Totale 10.572
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.065 0 0 0 0 0 0 208 113 119 122 292 211
2020/20211.972 118 214 31 218 257 78 229 55 249 116 368 39
2021/20222.127 187 214 58 116 110 67 38 313 81 152 327 464
2022/20234.473 521 587 354 602 337 527 238 351 642 90 160 64
2023/20242.306 85 659 77 158 90 307 144 151 34 66 251 284
2024/20251.410 103 166 403 151 380 197 10 0 0 0 0 0
Totale 18.738